Wordt geladen...
Incremental cost-effectiveness of the second Xpert MTB/RIF assay to detect Mycobacterium tuberculosis
BACKGROUND: Due to the non-homogeneity of specimens collected from tuberculosis (TB) suspects, repeated Xpert MTB/RIF (Xpert) may have potential clinical benefits. Incremental cost-effectiveness was analyzed for the second Xpert assay to detect Mycobacterium tuberculosis (Mtb) and rifampicin (RIF) r...
Bewaard in:
| Gepubliceerd in: | J Thorac Dis |
|---|---|
| Hoofdauteurs: | , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
AME Publishing Company
2018
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5906334/ https://ncbi.nlm.nih.gov/pubmed/29707322 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jtd.2018.02.60 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|